Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study

Table 2 Medical and surgical treatment within 3 mo of diagnosis by ethnic group

	White European, n (%)	Indian, n (%)	Pakistani, n (%)	Other, n (%)	Total, n (%)
UC
None	5 (4.6)	3 (6.4)	1 (7.7)	2 (9.5)	11 (5.8)
5-ASA	88 (81.5)	42 (89.4)	12 (92.3)	12 (57.1)	154 (81.4)
Steroids	36 (33.3)	16 (34.0)	2 (15.4)	4 (19.0)	58 (30.7)
IM	0	0	0	0	0
Biologics	7 (6.5)	0	0	3 (14.3)	10 (5.2)
Ciclosporin	2 (1.9)	0	0	0	2 (1.0)
Surgery	2 (1.9)	0	0	2 (9.5)	4 (2.1)
CD
None	7 (8.5)	2 (16.7)	0	0	9
5-ASA	31 (37.8)	6 (50.0)	2 (22.2)	2 (28.6)	43
Steroids	34 (41.5)	6 (50.0)	6 (66.7)	4 (57.1)	50
IM	19 (23.2)	2 (16.7)	4 (44.4)	3 (42.9)	28
Biologics	12 (14.6)	0	1 (11.1)	1 (14.3)	14
Other	1 (1.2)	0	0	0	1
Surgery	3 (3.7)	0	0	0	3

IM: Immunomodulators; CD: Crohn’s disease; UC: Ulcerative colitis; 5-ASA: 5-aminosalicylic acid.